Medtronic presented real-world clinical results that compared glycemic outcomes for 1,736 individuals before and after using the InPen smart1 insulin pen for 90 days with a glucose monitor Medtronic ...

You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.

SAN DIEGO, April 8, 2020 /PRNewswire/ -- Companion Medical, manufacturer of InPen, the FDA-cleared intelligent insulin system for people with diabetes who practice multiple daily injections (MDI), ...

The InPen system uses a smart pen and Bluetooth-enabled app to calculate insulin doses, issue dose reminders, track active insulin and send reports to caregivers. Credit: Companion Medical Companion ...

CGM technology could become a cornerstone in modern diabetes management. Credit: Halfpoint via Shutterstock. In an advancement for diabetes management, the US Food and Drug Administration (FDA) has ...

New Smart MDI system will be the first system to deliver real-time, personalized insights on when and how much to dose including for missed or inaccurate mealtime doses. GALWAY, Ireland, Nov. 20, 2024 ...

Companion Medical today confirmed that it has received clearance from the FDA for its InPen bolus calculator for fixed dosing and meal estimation Companion Medical today confirmed that it has received ...

Medtronic plc has reported the launch of the Inpen integrated with real-time Guardian Connect continuous glucose monitoring (CGM) data. Inpen is the first U.S. FDA-cleared smart insulin pen on the ...

Medtronic MDT continues to grab headlines with respect to its Diabetes management business update. Following two back-to-back European approvals last month for its InPen smart insulin pen as well as ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted clearance for the Android version of the InPen app, making ...

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and commercialization of the first and only long-term, ...